Canagliflozin

Dapagliflozin

Empagliflozin

SGLT2 inhibitors

Brands:

  • Invokana (canagliflozin)
  • Forxiga (dapagliflozin)
  • Jardiance (empagliflozin)

Indications:

Type 2 diabetes mellitus

  • Major Side Effects:

    constipationurinary tract infectionsnausea and vomitingrash
  • Serious Side Effects:

    urosepsisFournier's gangrenerenal impairment

    Cautions:

    • diabetic ketoacidosis
    • eGFR < 60

    Monitoring Requirement:

    • ketone level
    • renal function
  • Remarks:
    • MHRA: increased risk lower limb amputation (canagliflozin)
    • Monitor ketone level (during interruption in case of major surgery or acute serious illness)

Linagliptin

Sitagliptin

Saxagliptin

Vildagliptin

DPP-4 inhibitors

Brands:

  • Januvia (sitagliptin)
  • Trajenta (linagliptin)

Indications:

Type 2 diabetes mellitus

  • Major Side Effects:

    headacheconstipationdizzinesshepatic disorderpancreatitishypersensitivityvomitingupper respiratory infectionangioedema
  • Serious Side Effects:

    Stevens-Johnson syndromerenal impairment

    Cautions:

    • Alogliptin: reduce dose if CrCl < 50ml/min.
    • Sitagliptin: reduce dose if CrCl< 45ml/min.

    Monitoring Requirement:

    • renal function
  • Remarks:
    • sitagliptin: do not use in renal impairment
    • saxagliptin: skin reactions
    • vildagliptin: liver toxicity (perform liver function tests before and every 3 months)

Liraglutide

Exenatide

Lixisenatide

GLP-1 agonist

Brands:

  • Saxenda, Victoza (liraglutide)
  • Byetta (exenatide)
  • Lyxumia (lixisenatide)

Indications:

Type 2 diabetes mellitus

  • Major Side Effects:

    gastrointestinal disturbanceskin reactionrenal impairmentheadachedrowsinessappetite decreasedvomitingtaste altered
  • Serious Side Effects:

    acute pancreatitis

    Cautions:

    • MHRA: diabetic ketoacidosis
  • Remarks:
    • Only for BMI ≥35 + have specific psychological or medical problems associated with obesity Or
    • BMI ≤35 but insulin therapy would have significant occupational implications Or
    • Weight loss would benefit

Metformin

Biguanide

Brands:

  • Glucophage

Indications:

Type 2 diabetes mellitus

  • Major Side Effects:

    nausea & vomitingabdominal paintaste disturbancevitamin B12 deficiency
  • Serious Side Effects:

    lactic acidosis

    Cautions:

    • Stop metformin when eGFR <30 mL/min/1.73
    • Symptoms and sign of lactic acidosis: abdominal pain, anorexia, hypothermia, lethargy, nausea vomiting, respiratory distress; increased risk when: renal altered function, cardiac or respiratory failure
  • Remarks:
    • Metformin helps weight loss, reduce risk of hypoglycaemia and long-term cardiovascular benefits

Insulin

Insulin

Brands:

  • Rapid-acting: regular insulin (Humulin R, Insuman, Actrapid®)
  • Rapid-acting: insulin lispro (Humalog®, Lyumjev®)
  • Rapid-acting: insulin aspart (Fiasp®, NovoRapid®)
  • Intermediate: Isophane insulin (Humulin I, Insulatard®, Insuman Basal, Novolin N)
  • Intermediate: Insulin zinc
  • Long-acting: Insulin glargine (Abasaglar®, Lantus®, Toujeo®, Semglee®) - once daily
  • Long-acting: Insulin detemir (Levemir®) Twice daily
  • Long-acting: Insulin Degludec

Indications:

type 1 diabetes

type 2 diabetes

  • Major Side Effects:

    weight gaintransient altered visionoedemaskin reaction
  • Serious Side Effects:

    insulin neuritis

    Cautions:

    • You need to tell DVLA if:
    • your insulin treatment lasts (or will last) over 3 months
    • you had gestational diabetes (diabetes associated with pregnancy) and your insulin treatment lasts over 3 months after the birth
    • you get disabling hypoglycaemia (low blood sugar) - or a medical professional has told you that you’re at risk of developing it

    Monitoring Requirement:

    • blood glucose level
  • Remarks:
    • Leave insulin in room temperature for 30mins before using
    • Soluble insulins and long-acting insulin analogues should be clear and colourless and must not be used if they appear cloudy or discoloured
    • If injecting more than 50 units (0.5 mL of U100 insulin), many experts recommend splitting the injection into separate areas to facilitate absorption
    • The needle should be left in the skin for 5–10 seconds (or longer for large doses) o avoid leakage
    • Apply gentle pressure over the injection site for several seconds after withdrawing the needle
    • Rapid-acting: onset of action 15min; duration 2-5 hours
    • Intermediate-actin: onset of action 1-2 hrs; duration 11-24hrs
    • Long-acting: duration of action up to 24hours

Pioglitazone

Rosiglitazone

Thiazolidinediones

Indications:

  • Major Side Effects:

    numbnessvisual impairmentweight gaininsomniainfectionbone fracture
  • Serious Side Effects:

    bladder cancerhepatitis (liver toxicity)heart failure

    Cautions:

    • Liver toxicity
    • heart failure

    Monitoring Requirement:

    • liver function tests
  • Remarks:

Salbutamol

Terbutaline

Short-acting beta-agonist

Indications:

Asthma

  • Major Side Effects:

    cold hands and feet
  • Serious Side Effects:

  • Remarks:

Amitriptyline

Lofepramine

Tricyclic antidepressants

Indications:

Depression

  • Major Side Effects:

    dry mouthblurred visionhypotensionsedationsexual dysfunction
  • Serious Side Effects:

    extrapyramidal symptoms (tremor and dyskinesia)

    Cautions:

    • elderly
    • history of cardiovascular disease
    • epilepsy
  • Remarks:

Sertraline

Fluoxetine

Citalopram

SSRI

Indications:

Depression

  • Major Side Effects:

    Dizziness and confusionGastrointestinal disconfortDiarrhoeaConstipationQT prolongation
  • Serious Side Effects:

    sexual dysfunctionSerotonin syndrome
  • Remarks:
    • SSRI is the most tolerated group of antidepressant, therefore considered as 1st line option for treatment of depression
    • Sertraline - safe to be use in MI and Angina
    • Fluoxetine is the only SSRi suitable for children <18
    • Overdose: nausea, vomiting, agitation, tremor etc.